
Tom Vanden Berghe
@tomvberghe
Expert in Cell death and Disease
ID: 363078993
https://www.vanden-berghe-lab.com 27-08-2011 14:01:49
329 Tweet
494 Takipçi
417 Takip Edilen



Here is our latest review by Francesca Maremonti in Cell Death & Differentiation. From a definition of #ferroptosis to clinical trial design for #ferrostatins. Great to work with Mauro Giacca and King's College London on advances tharapies. Ferroptosis (SPP 2306) nature.com/articles/s4141…



Cell Death-Related Ubiquitin Modifications in Inflammatory Syndromes: From Mice to Men mdpi.com/1682504 #mdpibiomedicines via Biomedicines MDPI


Another memorable CSHA ferroptosis meeting in Suzhou China. Thx to organisers and cell death community! Cold Spring Harbor Asia #ferroptosis



While at Dana-Farber, Brian Bruker (now OHSU Knight Cancer Institute) started the personalized medicine revolution with the first targeted cancer drug, imatinib. The first of a series of BCR-ABL inhibitors that made Ph+ #CML a chronic disease. A transformative discovery.



🚀 Exciting opportunity! 🎓 The PhD program in Cancer and Immunology in Lausanne is accepting applications! If you're passionate about advancing research in cancer or immunology, we want to hear from you! 🌟 #PhD #CancerResearch #Immunology unil.ch/cancer-immunol… via Université de Lausanne


Harnessing ferroptosis for precision oncology: challenges and prospects. New #openaccess Review from Fernández-Acosta Tom Vanden Berghe and co as part of our ‘#Ferroptosis’ Collection bmcbiol.biomedcentral.com/articles/10.11…





